palynziq
(pegvaliase-pqpz)BioMarin Pharmaceutical Inc.
Usage: Palynziq is indicated for reducing blood phenylalanine levels in adult patients with phenylketonuria (PKU) who have uncontrolled concentrations above 600 micromol/L despite current treatment.